DAWN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $5,057,395.18

Day One Biopharmaceuticals Insider Trading History Chart

Day One Biopharmaceuticals Share Price & Price History

^$7.33

▲ +0.19 (2.66%)

As of 04/22/2025 05:00 PM ET

Days: 30 | 90 | 365

Day One Biopharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/18/2025	Adam Dubow	General Counsel	Sell	4,646	$11.96	$55,566.16	39,602
2/18/2025	Charles N. York, II	CFO	Sell	4,370	$11.96	$52,265.20	252,638
2/18/2025	Jeremy Bender	CEO	Sell	12,048	$11.96	$144,094.08	128,015
12/10/2024	Samuel C. Blackman	Insider	Sell	30,000	$13.31	$399,300.00	1,034,015
11/11/2024	Samuel C. Blackman	Insider	Sell	10,000	$16.10	$161,000.00	1,057,535
11/7/2024	Samuel C. Blackman	Insider	Sell	11,245	$16.03	$180,257.35	1,085,790
10/31/2024	Samuel C. Blackman	Insider	Sell	500	$16.02	$8,010.00	1,097,035
9/10/2024	Samuel C. Blackman	Insider	Sell	30,000	$14.22	$426,600.00	1,097,535
8/16/2024	Adam Dubow	General Counsel	Sell	3,202	$14.00	$44,828.00	26,928
8/16/2024	Charles N. York, II	CFO	Sell	2,633	$14.00	$36,862.00	232,485
8/16/2024	Jeremy Bender	CEO	Sell	10,681	$14.00	$149,534.00	98,932
8/16/2024	Samuel C. Blackman	Insider	Sell	2,232	$14.00	$31,248.00	1,127,535
7/16/2024	Samuel C. Blackman	Insider	Sell	20,000	$16.01	$320,200.00	1,121,081
6/21/2024	Saira Ramasastry	Director	Sell	10,000	$13.19	$131,900.00	40,485
5/16/2024	Adam Dubow	General Counsel	Sell	3,253	$16.08	$52,308.24	21,731
5/16/2024	Charles N. York, II	CFO	Sell	2,675	$16.08	$43,014.00	224,868
5/16/2024	Jeremy Bender	CEO	Sell	7,873	$16.08	$126,597.84	654,728
5/16/2024	Samuel C. Blackman	Insider	Sell	2,267	$16.08	$36,453.36	1,171,081
5/10/2024	Samuel C. Blackman	Insider	Sell	10,000	$16.37	$163,700.00	1,164,662
5/3/2024	Charles N. York, II	CFO	Sell	8,078	$17.85	$144,192.30	217,293
5/3/2024	Jeremy Bender	CEO	Sell	9,154	$17.85	$163,398.90	642,602
5/1/2024	Charles N. York, II	CFO	Sell	52,183	$17.89	$933,553.87	225,571
5/1/2024	Jeremy Bender	CEO	Sell	70,051	$17.88	$1,252,511.88	651,762
4/18/2024	Samuel C. Blackman	Insider	Sell	10,000	$16.02	$160,200.00	1,174,662
3/25/2024	Samuel C. Blackman	Insider	Sell	10,000	$16.01	$160,100.00	1,184,662
2/27/2024	Samuel C. Blackman	Insider	Sell	20,000	$16.11	$322,200.00	1,224,662
2/16/2024	Adam Dubow	General Counsel	Sell	3,242	$15.25	$49,440.50	16,585
2/16/2024	Charles N. York, II	CFO	Sell	2,666	$15.25	$40,656.50	277,754
2/16/2024	Jeremy Bender	CEO	Sell	7,615	$15.25	$116,128.75	721,813
2/16/2024	Samuel C. Blackman	Insider	Sell	2,258	$15.25	$34,434.50	1,244,662
11/16/2023	Adam Dubow	General Counsel	Sell	5,313	$11.69	$62,108.97	11,428
11/16/2023	Charles N. York, II	CFO	Sell	956	$11.69	$11,175.64	270,170
11/16/2023	Jeremy Bender	CEO	Sell	3,107	$11.69	$36,320.83	709,429
11/16/2023	Samuel C. Blackman	Insider	Sell	709	$11.69	$8,288.21	1,238,234
10/19/2023	Ai Day1 Llc	Major Shareholder	Buy	384,400	$10.06	$3,867,064.00	12,817,935
8/17/2023	Charles N. York, II	CFO	Sell	922	$13.86	$12,778.92	267,501
8/17/2023	Jeremy Bender	CEO	Sell	2,996	$13.86	$41,524.56	704,224
8/17/2023	Samuel C. Blackman	Insider	Sell	668	$13.86	$9,258.48	1,236,319
6/9/2023	Ai Day1 Llc	Major Shareholder	Buy	769,230	$13.00	$9,999,990.00	11,453,868
6/5/2023	Samuel C. Blackman	Insider	Sell	1,229	$16.00	$19,664.00	1,234,363
5/16/2023	Charles N. York, II	CFO	Sell	955	$13.12	$12,529.60	264,798
5/16/2023	Jeremy Bender	CEO	Sell	3,104	$13.12	$40,724.48	1,179,484
5/16/2023	Samuel C. Blackman	Insider	Sell	692	$13.12	$9,079.04	1,235,592
3/10/2023	Samuel C. Blackman	Insider	Sell	10,000	$18.05	$180,500.00	1,233,660
3/7/2023	Jeremy Bender	CEO	Sell	12,500	$20.01	$250,125.00	1,174,276
2/16/2023	Charles N. York, II	CFO	Sell	930	$19.57	$18,200.10	271,505
2/16/2023	Jeremy Bender	CEO	Sell	3,022	$19.57	$59,140.54	1,186,776
2/16/2023	Samuel C. Blackman	Insider	Sell	674	$19.57	$13,190.18	1,243,660
2/10/2023	Samuel C. Blackman	Insider	Sell	10,000	$20.07	$200,700.00	1,241,710
1/23/2023	Jeremy Bender	CEO	Sell	12,500	$22.00	$275,000.00	1,181,486
1/20/2023	Charles N. York, II	CFO	Sell	10,000	$22.75	$227,500.00	268,810
1/10/2023	Samuel C. Blackman	Insider	Sell	10,000	$22.86	$228,600.00	1,250,148
1/3/2023	Julie Papanek Grant	Director	Sell	25,000	$20.65	$516,250.00	380,000
12/21/2022	Jeremy Bender	CEO	Sell	12,500	$20.32	$254,000.00	1,192,424
12/20/2022	Charles N. York, II	CFO	Sell	10,000	$20.07	$200,700.00	276,497
12/8/2022	Julie Papanek Grant	Director	Sell	4,358	$22.08	$96,224.64	405,000
12/1/2022	Julie Papanek Grant	Director	Sell	5,000	$21.75	$108,750.00	414,358
12/1/2022	Samuel C. Blackman	Insider	Sell	10,000	$21.45	$214,500.00	1,260,148
11/21/2022	Charles N. York, II	CFO	Sell	10,000	$20.76	$207,600.00	286,497
11/21/2022	Jeremy Bender	CEO	Sell	12,500	$20.76	$259,500.00	1,204,924
11/16/2022	Charles N. York, II	CFO	Sell	430	$21.46	$9,227.80	296,497
11/16/2022	Jeremy Bender	CEO	Sell	1,513	$21.46	$32,468.98	1,217,424
11/16/2022	Samuel C. Blackman	Insider	Sell	377	$21.46	$8,090.42	1,270,148
11/1/2022	Charles N. York, II	CFO	Sell	10,000	$20.03	$200,300.00	294,401
11/1/2022	Jeremy Bender	CEO	Sell	12,500	$20.03	$250,375.00	1,215,375
11/1/2022	Julie Papanek Grant	Director	Sell	5,000	$20.04	$100,200.00	424,358
10/3/2022	Charles N. York, II	CFO	Sell	10,000	$20.05	$200,500.00	304,401
10/3/2022	Jeremy Bender	CEO	Sell	12,500	$20.05	$250,625.00	1,227,875
10/3/2022	Julie Papanek Grant	Director	Sell	5,000	$20.06	$100,300.00	434,358
9/21/2022	Julie Papanek Grant	Director	Sell	613,603	$18.55	$11,382,335.65	8,464,301
9/20/2022	Xi L.P. Canaan	Major Shareholder	Sell	148,670	$19.51	$2,900,551.70	9,077,904
9/19/2022	Julie Papanek Grant	Director	Sell	76,725	$20.57	$1,578,233.25	9,226,574
9/16/2022	Xi L.P. Canaan	Major Shareholder	Sell	115,307	$21.55	$2,484,865.85	9,303,299
9/15/2022	Julie Papanek Grant	Director	Sell	51,281	$22.85	$1,171,770.85	9,418,606
9/14/2022	Xi L.P. Canaan	Major Shareholder	Sell	106,111	$23.68	$2,512,708.48	9,469,887
9/13/2022	Julie Papanek Grant	Director	Sell	87,647	$24.40	$2,138,586.80	9,575,998
9/2/2022	Papanek Julie Grant	Director	Sell	5,000	$23.82	$119,100.00	439,358
8/16/2022	Charles N. York, II	CFO	Sell	1,089	$24.31	$26,473.59	324,401
8/16/2022	Jeremy Bender	CEO	Sell	4,003	$24.31	$97,312.93	1,252,875
8/16/2022	Samuel C. Blackman	Insider	Sell	941	$24.31	$22,875.71	1,299,338
8/4/2022	Charles N. York, II	CFO	Sell	10,000	$20.05	$200,500.00	321,365
8/4/2022	Jeremy Bender	CEO	Sell	12,500	$20.00	$250,000.00	1,246,192
8/4/2022	Papanek Julie Grant	Director	Sell	5,000	$20.00	$100,000.00	454,358
8/1/2022	Samuel C. Blackman	Insider	Sell	10,000	$16.88	$168,800.00	1,296,718
7/18/2022	Charles N. York, II	CFO	Sell	2,500	$20.00	$50,000.00	331,365
7/18/2022	Papanek Julie Grant	Director	Sell	2,600	$20.00	$52,000.00	459,358
7/8/2022	Charles N. York, II	CFO	Sell	1,416	$20.00	$28,320.00	333,865
7/8/2022	Jeremy Bender	CEO	Sell	1,795	$20.00	$35,900.00	1,261,292
7/8/2022	Papanek Julie Grant	Director	Sell	1,242	$20.00	$24,840.00	461,958
7/5/2022	Charles N. York, II	CFO	Sell	800	$20.00	$16,000.00	335,281
7/5/2022	Jeremy Bender	CEO	Sell	857	$20.00	$17,140.00	1,263,087
7/1/2022	Charles N. York, II	CFO	Sell	1,479	$20.00	$29,580.00	336,081
7/1/2022	Jeremy Bender	CEO	Sell	1,746	$20.00	$34,920.00	1,263,944
7/1/2022	Papanek Julie Grant	Director	Sell	1,000	$20.00	$20,000.00	464,000
7/1/2022	Samuel C. Blackman	Insider	Sell	10,000	$18.72	$187,200.00	1,306,718
6/17/2022	Ai Day1 Llc	Major Shareholder	Buy	1,200,000	$15.00	$18,000,000.00	10,684,638
6/17/2022	Michael Gladstone	Director	Buy	766,667	$15.00	$11,500,005.00	766,667
6/15/2022	Samuel C. Blackman	Insider	Sell	50,000	$16.26	$813,000.00	1,316,718

See Full Table

SEC Filings (Institutional Ownership Changes) for Day One Biopharmaceuticals (NASDAQ:DAWN)

87.95% of Day One Biopharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Day One Biopharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/17/2025	Exchange Traded Concepts LLC	14,693	$0.12M	0.0%	+19.6%	0.014%
4/16/2025	Wealth Enhancement Advisory Services LLC	11,154	$88K	0.0%	N/A	0.011%
4/14/2025	Pallas Capital Advisors LLC	11,005	$87K	0.0%	N/A	0.011%
4/10/2025	Hennion & Walsh Asset Management Inc.	137,968	$1.09M	0.0%	+13.9%	0.136%
4/8/2025	Rhumbline Advisers	81,844	$0.65M	0.0%	+8.3%	0.081%
3/24/2025	Wellington Management Group LLP	731,303	$9.27M	0.0%	+1.3%	0.722%
2/19/2025	GF Fund Management CO. LTD.	2,117	$27K	0.0%	N/A	0.002%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	75,579	$0.96M	0.0%	+15.9%	0.075%
2/17/2025	Woodline Partners LP	798,925	$10.12M	0.1%	+0.2%	0.792%
2/17/2025	Vestal Point Capital LP	1,440,000	$18.25M	1.1%	-42.4%	1.428%
2/17/2025	Squarepoint Ops LLC	30,029	$0.38M	0.0%	N/A	0.030%
2/17/2025	Two Sigma Advisers LP	106,600	$1.35M	0.0%	-7.4%	0.106%
2/17/2025	Two Sigma Investments LP	271,776	$3.44M	0.0%	-33.3%	0.269%
2/17/2025	Stonepine Capital Management LLC	235,000	$2.98M	2.4%	+14.3%	0.233%
2/17/2025	Tema Etfs LLC	85,761	$1.09M	0.5%	N/A	0.085%
2/17/2025	Sherbrooke Park Advisers LLC	14,865	$0.19M	0.1%	N/A	0.015%
2/17/2025	Sphera Funds Management LTD.	334,987	$4.24M	0.8%	-3.6%	0.332%
2/17/2025	Rafferty Asset Management LLC	159,408	$2.02M	0.0%	+16.8%	0.158%
2/17/2025	ProShare Advisors LLC	19,394	$0.25M	0.0%	+23.5%	0.019%
2/17/2025	Parkman Healthcare Partners LLC	1,000,474	$12.68M	1.7%	+8.3%	0.992%
2/17/2025	Parkwood LLC	275,000	$3.48M	0.4%	N/A	0.273%
2/17/2025	Man Group plc	12,799	$0.16M	0.0%	N/A	0.013%
2/17/2025	Nuveen Asset Management LLC	141,298	$1.79M	0.0%	-13.7%	0.140%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	50,020	$0.63M	0.1%	N/A	0.050%
2/17/2025	Millennium Management LLC	192,100	$2.43M	0.0%	+80.4%	0.190%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	35,843	$0.45M	0.0%	+5.6%	0.036%
2/17/2025	Janus Henderson Group PLC	1,306,220	$16.56M	0.0%	-40.0%	1.295%
2/17/2025	Hudson Bay Capital Management LP	920,108	$11.66M	0.0%	+27.8%	0.912%
2/17/2025	Graham Capital Management L.P.	27,950	$0.35M	0.0%	+46.4%	0.028%
2/17/2025	Estuary Capital Management LP	3,716,777	$47.09M	13.8%	+35.5%	3.686%
2/17/2025	D. E. Shaw & Co. Inc.	146,385	$1.86M	0.0%	+2.3%	0.145%
2/17/2025	Deutsche Bank AG	358,920	$4.55M	0.0%	+11.0%	0.356%
2/17/2025	DAFNA Capital Management LLC	731,363	$9.27M	2.4%	-2.5%	0.725%
2/17/2025	Deerfield Management Company L.P. Series C	2,596,033	$32.89M	0.6%	-0.8%	2.574%
2/17/2025	Cetera Investment Advisers	31,571	$0.40M	0.0%	+44.7%	0.031%
2/17/2025	Bridgefront Capital LLC	18,874	$0.24M	0.1%	N/A	0.019%
2/17/2025	Balyasny Asset Management L.P.	29,455	$0.37M	0.0%	N/A	0.029%
2/17/2025	Bank of America Corp DE	20,534	$0.26M	0.0%	-89.3%	0.020%
2/17/2025	BNP Paribas Financial Markets	36,685	$0.47M	0.0%	N/A	0.036%
2/17/2025	Ameriprise Financial Inc.	18,928	$0.24M	0.0%	-30.2%	0.019%
2/17/2025	Alyeska Investment Group L.P.	2,512,187	$31.83M	0.1%	N/A	2.491%
2/14/2025	Boxer Capital Management LLC	1,189,943	$15.08M	1.3%	N/A	1.180%
2/14/2025	RA Capital Management L.P.	5,755,577	$72.92M	1.0%	-26.9%	5.707%
2/14/2025	Northern Trust Corp	547,050	$6.93M	0.0%	+10.5%	0.542%
2/14/2025	The Manufacturers Life Insurance Company	46,999	$0.60M	0.0%	-3.1%	0.047%
2/14/2025	Virtus ETF Advisers LLC	27,296	$0.35M	0.1%	+7.1%	0.027%
2/14/2025	Nebula Research & Development LLC	19,804	$0.25M	0.0%	+95.9%	0.020%
2/14/2025	Voya Investment Management LLC	15,801	$0.20M	0.0%	-9.4%	0.016%
2/14/2025	Integrated Wealth Concepts LLC	17,274	$0.22M	0.0%	N/A	0.017%
2/14/2025	Adage Capital Partners GP L.L.C.	800,000	$10.14M	0.0%	-11.1%	0.793%
2/14/2025	Price T Rowe Associates Inc. MD	1,706,112	$21.62M	0.0%	-33.0%	1.692%
2/14/2025	Hsbc Holdings PLC	38,583	$0.48M	0.0%	N/A	0.038%
2/14/2025	Tower Research Capital LLC TRC	10,657	$0.14M	0.0%	+911.1%	0.011%
2/14/2025	MetLife Investment Management LLC	34,248	$0.43M	0.0%	+12.4%	0.034%
2/14/2025	Dimensional Fund Advisors LP	927,017	$11.75M	0.0%	+10.9%	0.919%
2/13/2025	Marshall Wace LLP	1,097,762	$13.91M	0.0%	N/A	1.089%
2/13/2025	Mariner LLC	11,669	$0.15M	0.0%	-47.1%	0.012%
2/13/2025	Optimize Financial Inc	15,487	$0.20M	0.1%	N/A	0.015%
2/13/2025	Kennedy Capital Management LLC	193,912	$2.46M	0.1%	+2.4%	0.192%
2/13/2025	CenterBook Partners LP	100,735	$1.28M	0.1%	N/A	0.100%
2/13/2025	Renaissance Technologies LLC	243,740	$3.09M	0.0%	+157.0%	0.242%
2/13/2025	Legal & General Group Plc	57,623	$0.73M	0.0%	-3.6%	0.057%
2/13/2025	FMR LLC	12,887,467	$163.28M	0.0%	+73.9%	12.779%
2/13/2025	Wells Fargo & Company MN	51,735	$0.66M	0.0%	-8.4%	0.051%
2/12/2025	ExodusPoint Capital Management LP	215,137	$2.73M	0.0%	N/A	0.213%
2/12/2025	Trexquant Investment LP	87,972	$1.12M	0.0%	N/A	0.087%
2/12/2025	Geode Capital Management LLC	1,462,982	$18.54M	0.0%	+2.1%	1.451%
2/12/2025	Diametric Capital LP	10,728	$0.14M	0.1%	-39.5%	0.011%
2/12/2025	Franklin Resources Inc.	3,882,952	$49.20M	0.0%	+0.3%	3.850%
2/12/2025	Wellington Management Group LLP	731,303	$9.27M	0.0%	+1.3%	0.725%
2/12/2025	Pictet Asset Management Holding SA	3,490,064	$44.22M	0.0%	+17.0%	3.461%
2/12/2025	Norges Bank	169,000	$2.14M	0.0%	N/A	0.168%
2/12/2025	NEOS Investment Management LLC	85,761	$1.09M	0.0%	+8.7%	0.085%
2/12/2025	BIT Capital GmbH	171,714	$2.18M	0.2%	+41.8%	0.170%
2/11/2025	Corebridge Financial Inc.	25,805	$0.33M	0.0%	-7.0%	0.026%
2/11/2025	Vanguard Group Inc.	5,848,923	$74.11M	0.0%	-0.7%	5.800%
2/11/2025	KLP Kapitalforvaltning AS	11,800	$0.15M	0.0%	N/A	0.012%
2/11/2025	Teacher Retirement System of Texas	17,825	$0.23M	0.0%	+20.9%	0.018%
2/11/2025	Intech Investment Management LLC	34,888	$0.44M	0.0%	+50.1%	0.035%
2/10/2025	Skandinaviska Enskilda Banken AB publ	41,771	$0.53M	0.0%	N/A	0.041%
2/10/2025	Swiss National Bank	117,800	$1.49M	0.0%	+2.6%	0.117%
2/7/2025	Essex Investment Management Co. LLC	207,574	$2.63M	0.5%	+12.7%	0.206%
2/7/2025	AlphaQuest LLC	3,396	$43K	0.0%	-56.2%	0.003%
2/7/2025	Jackson Creek Investment Advisors LLC	103,592	$1.31M	0.4%	N/A	0.103%
2/7/2025	E Fund Management Co. Ltd.	11,276	$0.14M	0.0%	N/A	0.011%
2/6/2025	Charles Schwab Investment Management Inc.	535,501	$6.79M	0.0%	+5.5%	0.531%
2/5/2025	Fisher Asset Management LLC	89,132	$1.13M	0.0%	+21.6%	0.088%
2/4/2025	Bank of New York Mellon Corp	244,829	$3.10M	0.0%	+43.4%	0.243%
2/3/2025	Handelsbanken Fonder AB	31,500	$0.40M	0.0%	+16.7%	0.031%
2/3/2025	TimesSquare Capital Management LLC	1,710,926	$21.68M	0.3%	-6.4%	1.697%
1/30/2025	Rhumbline Advisers	75,553	$0.96M	0.0%	-2.3%	0.075%
1/29/2025	Legato Capital Management LLC	62,027	$0.79M	0.1%	-1.8%	0.062%
1/24/2025	China Universal Asset Management Co. Ltd.	21,383	$0.27M	0.0%	+11.4%	0.021%
1/23/2025	R Squared Ltd	2,450	$31K	0.0%	N/A	0.002%
1/17/2025	SG Americas Securities LLC	68,374	$0.87M	0.0%	N/A	0.068%
1/15/2025	Hennion & Walsh Asset Management Inc.	121,167	$1.54M	0.1%	+90.6%	0.120%
11/27/2024	Franklin Resources Inc.	3,869,632	$55.34M	0.0%	+2.3%	3.837%
11/16/2024	Geode Capital Management LLC	1,432,697	$19.96M	0.0%	+10.5%	1.421%
11/15/2024	Frazier Life Sciences Management L.P.	689,655	$9.61M	0.4%	N/A	0.684%
11/15/2024	XTX Topco Ltd	12,778	$0.18M	0.0%	N/A	0.013%

Data available starting January 2016

See Full Table

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.

Today's Range

Now: $7.33

$7.11

$7.39

50 Day Range

MA: $8.62

$6.71

$12.43

52 Week Range

Now: $7.33

$6.41

$18.07

Volume

844,930 shs

Average Volume

1,122,671 shs

Market Capitalization

$742.92 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Day One Biopharmaceuticals?: Day One Biopharmaceuticals' top insider investors include:
Ai Day1 Llc (Major Shareholder)
Samuel C Blackman (Insider)
Jeremy Bender (CEO)
Charles N York II (CFO)
Saira Ramasastry (Director)
Adam Dubow (General Counsel)
Learn More about top insider investors at Day One Biopharmaceuticals.
Who are the major institutional investors of Day One Biopharmaceuticals?: Day One Biopharmaceuticals' top institutional shareholders include:
Hennion & Walsh Asset Management Inc. — 0.14%
Rhumbline Advisers — 0.08%
Exchange Traded Concepts LLC — 0.01%
Wealth Enhancement Advisory Services LLC — 0.01%
Pallas Capital Advisors LLC — 0.01%
Learn More about top institutional investors of Day One Biopharmaceuticals stock.
Which major investors are buying Day One Biopharmaceuticals stock?: Within the previous quarter, DAWN stock was bought by institutional investors including:
Hennion & Walsh Asset Management Inc.
Wealth Enhancement Advisory Services LLC
Pallas Capital Advisors LLC
Rhumbline Advisers
Exchange Traded Concepts LLC